UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles

Biomaterials, 2012-07, Vol.33 (21), p.5414-5422

2012

Volltextzugriff (PDF)

Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies

Haematologica (Roma), 2013-02, Vol.98 (2), p.217-221

2013

Volltextzugriff (PDF)

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B

Journal of experimental & clinical cancer research, 2019-07, Vol.38 (1), p.332-332, Article 332

2019

Volltextzugriff (PDF)

Multifractality in human heartbeat dynamics

Nature (London), 1999-06, Vol.399 (6735), p.461-465

1999

Volltextzugriff (PDF)

Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells

Molecular cancer therapeutics, 2011-07, Vol.10 (7), p.1276-1288

2011

Volltextzugriff (PDF)

Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (14), p.4439-4450

2013

Volltextzugriff (PDF)

The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

Journal of investigative dermatology, 2013-04, Vol.133 (4), p.1052-1062

2013

Volltextzugriff (PDF)

Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel

PloS one, 2009-08, Vol.4 (8), p.e6691

2009

Volltextzugriff (PDF)

Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET

Journal of Nuclear Medicine, 2008-04, Vol.49 (4), p.667-673

2008

Volltextzugriff (PDF)

Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the Her2/neu Oncogene Product: In vitro and In vivo Studies

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23), p.8987-8995

2009

Volltextzugriff (PDF)

Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

Molecular cancer therapeutics, 2009-07, Vol.8 (7), p.1906-1915

2009

Volltextzugriff (PDF)

From 1/f noise to multifractal cascades in heartbeat dynamics

Chaos (Woodbury, N.Y.), 2001-09, Vol.11 (3), p.641-652

2001

Volltextzugriff (PDF)

Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein

Biomedicines, 2017-07, Vol.5 (3), p.42

2017

Volltextzugriff (PDF)

Controlling synchronization in an ensemble of globally coupled oscillators

Physical review letters, 2004-03, Vol.92 (11), p.114102.1-114102.4, Article 114102

2004

Volltextzugriff (PDF)

In vitro and in vivo Studies of a VEGF121/rGelonin Chimeric Fusion Toxin Targeting the Neovasculature of Solid Tumors

Proceedings of the National Academy of Sciences - PNAS, 2002-06, Vol.99 (12), p.7866-7871

2002

Volltextzugriff (PDF)

PET of Vascular Endothelial Growth Factor Receptor Expression

The Journal of nuclear medicine (1978), 2006-12, Vol.47 (12), p.2048-2056

2006

Volltextzugriff (PDF)

The great escape; the hallmarks of resistance to antiangiogenic therapy

Pharmacological reviews, 2015-04, Vol.67 (2), p.441-461

2015

Volltextzugriff (PDF)

The rGel/BLyS Fusion Toxin Inhibits Diffuse Large B-cell Lymphoma Growth In Vitro and In Vivo

Neoplasia (New York, N.Y.), 2010-05, Vol.12 (5), p.366-375

2010

Volltextzugriff (PDF)

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

Pharmacological reviews, 2015-10, Vol.67 (4), p.731-753

2015

Volltextzugriff (PDF)

Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy

Journal of controlled release, 2018-10, Vol.288, p.161-172

2018

Volltextzugriff (PDF)

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

BMC cancer, 2011-08, Vol.11 (1), p.358-358, Article 358

2011

Volltextzugriff (PDF)

Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties

The Journal of biological chemistry, 2011-02, Vol.286 (6), p.4165-4172

2011

Volltextzugriff (PDF)

Antitumor activity of fibroblast growth factor receptor 3–specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis

Molecular cancer therapeutics, 2008-04, Vol.7 (4), p.862-873

2008

Volltextzugriff (PDF)

A novel in vivo model using immunotoxin in the absence of p-glycoprotein to achieve ultra selective depletion of target cells: Applications in trogocytosis and beyond

Journal of immunological methods, 2020-08, Vol.483, p.112794, Article 112794

2020

Volltextzugriff (PDF)

Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome

Journal of controlled release, 2014-05, Vol.182, p.58-66

2014

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(364)
Mit Volltextzugriff
(362)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(405)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles

Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignancies

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B

Multifractality in human heartbeat dynamics

Development and characterization of a potent immunoconjugate targeting the Fn14 receptor on solid tumor cells

Antitumor Activity of a Humanized, Bivalent Immunotoxin Targeting Fn14-Positive Solid Tumors

The TWEAK Receptor Fn14 Is a Therapeutic Target in Melanoma: Immunotoxins Targeting Fn14 Receptor for Malignant Melanoma Treatment

Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel

Imaging of VEGF Receptor in a Rat Myocardial Infarction Model Using PET

Construction and Characterization of Novel, Recombinant Immunotoxins Targeting the Her2/neu Oncogene Product: In vitro and In vivo Studies

Recombinant CPE fused to tumor necrosis factor targets human ovarian cancer cells expressing the claudin-3 and claudin-4 receptors

From 1/f noise to multifractal cascades in heartbeat dynamics

Targeting of Tumor Neovasculature with GrB/VEGF121, a Novel Cytotoxic Fusion Protein

Controlling synchronization in an ensemble of globally coupled oscillators

In vitro and in vivo Studies of a VEGF121/rGelonin Chimeric Fusion Toxin Targeting the Neovasculature of Solid Tumors

PET of Vascular Endothelial Growth Factor Receptor Expression

The great escape; the hallmarks of resistance to antiangiogenic therapy

The rGel/BLyS Fusion Toxin Inhibits Diffuse Large B-cell Lymphoma Growth In Vitro and In Vivo

Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy

Light-enhanced VEGF121/rGel: A tumor targeted modality with vascular and immune-mediated efficacy

Cytotoxicity of VEGF121/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2

Convergent Potency of Internalized Gelonin Immunotoxins across Varied Cell Lines, Antigens, and Targeting Moieties

Antitumor activity of fibroblast growth factor receptor 3–specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis

A novel in vivo model using immunotoxin in the absence of p-glycoprotein to achieve ultra selective depletion of target cells: Applications in trogocytosis and beyond

Photochemical activation of the recombinant HER2-targeted fusion toxin MH3-B1/rGel; Impact of HER2 expression on treatment outcome

Suchergebnisse filtern